Knowledge is power. Are you facing a new diagnosis or recurrence of Pancreatic Cancer? The GI Connection Pancreatic Cancer Information Center has current, evidence-based information for you. Get the facts about the prevention, treatment, and living with Pancreatic Cancer. Stay up to date with news, tips, and features designed to keep you informed about the most recent developments and advances. Learn more about Pancreatic Cancer.
You are not alone—The GI Connection Community is the leading Social Media Application for individuals seeking information, inspiration, and support. With over 50,000 members the network offers patients and caregivers a thriving community to support the many ongoing needs. Login or register here.
April 18, 2018
First Interim Analysis in SEQUOIA Phase 3 Pancreatic Cancer Study
CancerConnect News: The first interim analysis of the SEQUOIA clinical study evaluating the novel immunotherapy drug pegilodecakin in patients with […]
Tags: AM0010, clinical trials, immunotherapy, Interleukin-10, News Tips and Features, News Tips and Features Other, Pancreatic Cancer, pegilodecakin, Precision Cancer Medicine, treatment
March 5, 2018
CancerConnect News: The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the anti-CTGF antibody, pamrevlumab, for […]
Tags: locally advanced, News Tips and Features, News Tips and Features Other, Pamrevlumab, Pancreatic Cancer, Precision Cancer Medicine, treatment
February 28, 2018
CancerConnect News: Clinical data from three ongoing larotrectinib (LOXO-101) clinical trials in patients whose tumors harbor tropomyosin receptor kinase (TRK) […]
Tags: larotrectinib, News Tips and Features, News Tips and Features Other, Pancreatic Cancer, Precision Cancer Medicine, treatment
August 15, 2017
A new clinical study will investigate napabucasin – an orally administered investigational agent designed to inhibit cancer stemness pathways by […]
Tags: Cancer Stemness Inhibitor Napabucasin, clinical trial, News Tips and Features, News Tips and Features Other, Pancreatic Cancer
July 11, 2017
Clinical Data on Immunotherapy AM0010 in Advanced Pancreatic Cancer Promising
ARMO BioSciences, Inc., a late-stage immuno-oncology company, announced clinical data on its lead investigational immuno-oncology drug AM0010 (pegilodecakin, PEGylated Interleukin-10) at […]
Tags: AM0010, immunotherapy, Interleukin-10, News Tips and Features, News Tips and Features Other, Pancreatic Cancer, pegilodecakin
March 2, 2017
Preliminary Results Suggest That Pamrevlumab is Promising in Pancreatic Cancer
Updated results from an ongoing clinical study of pamrevlumab (FG-3019) in combination with standard-of-care chemotherapy in patients with locally advanced […]
Tags: connective tissue growth factor, News Tips and Features, News Tips and Features Other, Pamrevlumab. FG-3019, Pancreatic Cancer
February 17, 2017
Proton beam therapy may improve outcomes for pancreatic cancer
Currently a standard treatment for several gastrointestinal cancers (GI) combines the use of chemotherapy and radiation followed by surgical resection. […]
Tags: News Tips and Features, News Tips and Features Other, Pancreatic Cancer, radiation
 |
 |
 |
